VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $197,000 | -43.6% | 10,192 | -25.6% | 0.08% | -38.5% |
| Q2 2022 | $349,000 | -12.8% | 13,692 | -11.9% | 0.12% | -1.6% |
| Q1 2022 | $400,000 | -30.6% | 15,542 | +13.0% | 0.12% | -17.9% |
| Q4 2021 | $576,000 | +10.3% | 13,752 | +14.7% | 0.15% | +6.3% |
| Q3 2021 | $522,000 | -7.6% | 11,992 | +0.4% | 0.14% | -11.2% |
| Q2 2021 | $565,000 | +1.4% | 11,942 | +9.8% | 0.16% | -6.4% |
| Q1 2021 | $557,000 | +17.3% | 10,872 | -38.8% | 0.17% | +14.8% |
| Q4 2020 | $475,000 | +13.1% | 17,752 | +45.1% | 0.15% | -3.2% |
| Q3 2020 | $420,000 | -6.2% | 12,232 | +11.9% | 0.15% | -13.0% |
| Q2 2020 | $448,000 | – | 10,932 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |